Stephen S Lipnik, MD | |
1 Mercado Street, Suite 130, Durango, CO 81301-7306 | |
(970) 247-1120 | |
(970) 247-3664 |
Full Name | Stephen S Lipnik |
---|---|
Gender | Male |
Speciality | Internal Medicine - Cardiovascular Disease |
Location | 1 Mercado Street, Durango, Colorado |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629043971 | NPI | - | NPPES |
65352769 | Medicaid | CO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 43368 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Stephen S Lipnik, MD 181 East 56th Avenue, Suite 100, Denver, CO 80216-1756 Ph: (303) 295-8737 | Stephen S Lipnik, MD 1 Mercado Street, Suite 130, Durango, CO 81301-7306 Ph: (970) 247-1120 |
News Archive
The Lupus Foundation of America (LFA) is pleased to announce the 2012 Gina M. Finzi Memorial Student Fellowship Program grantees. This unique program, established more than 25 years ago by former LFA President Dr. Sergio Finzi in honor of his daughter Gina who passed away from lupus, seeks to cultivate an interest in lupus research among young scientists by funding basic, clinical, translational, epidemiological, and behavioral research studies under the supervision of an established investigator.
Physician-scientists from Children's Hospital of Philadelphia presented updated efficacy and safety data on Kymriah-the first-ever U.S. Food and Drug Administration approved personalized CAR T-cell gene immunotherapy for aggressive blood cancers at the 60th American Society of Hematology annual meeting, as well as first-of-its-kind research on overcoming CAR T-cell resistance.
Patients who suffer stroke-like attacks can have mortality rates 20 per cent higher than the general population, new research finds, leading to calls for better stroke prevention strategies for those who experience a transient ischemic attack (TIA).
Autifony Therapeutics Limited ("Autifony"), which is pioneering the development of novel pharmaceutical treatments for hearing disorders, today announced that it has been awarded funding of £2.2 million towards a Phase IIa clinical trial in tinnitus patients with its lead compound AUT00063, by the UK's innovation agency, the Technology Strategy Board.
The U.S. Food and Drug Administration and the government of Mexico's National Service for Agro-Alimentary Public Health, Safety and Quality (SENASICA) and Federal Commission for the Protection from Sanitary Risks (COFEPRIS) signed a statement of intent forming a partnership to promote the safety of fresh and minimally processed agricultural products.
› Verified 7 days ago
Richard A Brown, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1010 Three Springs Blvd, Ste 110, Durango, CO 81301 Phone: 970-764-2750 Fax: 970-764-2778 | |
Dr. Richard L Converse Jr., MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Mercado St Ste 130, Durango, CO 81301 Phone: 970-247-1120 Fax: 970-247-1128 | |
Mr. Stuart Saslow, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1305 Escalante Dr Suite 204, Durango, CO 81303 Phone: 970-385-4022 Fax: 970-385-4337 | |
Dr. Erin Gray Clarkinson, DO Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1199 Main Ave Ste 206, Durango, CO 81301 Phone: 970-422-8147 | |
Lyla Saeed, Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1010 Three Springs Blvd Ste 270, Durango, CO 81301 Phone: 970-764-3800 Fax: 970-764-3840 | |
Dr. Eugenia M Miller, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Mercado Street, Suite 130, Durango, CO 81301 Phone: 970-247-1120 Fax: 970-247-3664 | |
Sarah E. Brown, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1010 Three Springs Blvd, Durango, CO 81301 Phone: 970-764-3352 Fax: 970-764-3375 |